Background & aims: Endoscopic improvement is an important treatment target for mild-to-moderate ulcerative colitis (UC). However, early endoscopic evaluation is not always feasible. We aimed to develop a clinical decision support tool to discriminate patients who have achieved endoscopic improvement from those with more severe inflammation following mesalamine induction therapy.


Complications, Drug Therapy, Endoscopic Improvement, Endoscopy, Leukocyte L1 Antigen Complex, Mesalamine, Mucosal Healing, therapeutic use, Ulcerative Colitis

Read More